Diaceutics has uniquely leveraged the capabilities of - case based reasoning -(CBR)to audit and analyze precedent market case studies and investment metrics of the pharmaceutical and diagnostics business models where they have actively or passively collaborated in a continuum of care. A series of proprietary decision frameworks have resulted.

Diaceutics tailor these frameworks around each specific personalized medicine initiative being considered, creating your very own internal consensus to optimizing personalized medicine.

Go to Contact page »